# Serum Creatinine Change / Renal Adverse Effect With Use of Non-steroidal Painkillers in Axial Spondyloarthritis Patients

> **NCT03582332** · PHASE4 · COMPLETED · sponsor: **Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh** · enrollment: 64 (actual)

## Conditions studied

- Axial Spondyloarthritis

## Interventions

- **DRUG:** Indomethacin SR, 75 Mg Oral Capsule, Extended Release
- **DRUG:** Indomethacin 25 Mg Oral Capsule
- **DRUG:** Etoricoxib 90 mg
- **DRUG:** Etoricoxib 60 mg

## Key facts

- **NCT ID:** NCT03582332
- **Lead sponsor:** Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-02
- **Primary completion:** 2016-06-23
- **Final completion:** 2016-06-23
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2018-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03582332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03582332, "Serum Creatinine Change / Renal Adverse Effect With Use of Non-steroidal Painkillers in Axial Spondyloarthritis Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03582332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*